logo
Share SHARE
FONT-SIZE Plus   Neg

Rite Aid Q4 Loss Reduces; Guides FY13 - Quick Facts

Drugstore chain operator Rite Aid Corp. (RAD) posted a narrower fourth-quarter net loss of $161.3 million or $0.18 per share versus a $205.69 million or $0.24 per share loss in the previous year, mainly benefitting from continued growth in same store sales and an extra week in the quarter.

The Camp Hill, Pennsylvania-based company's quarterly revenues totaled $7.15 billion, up 10.7 percent, compared with last year's $6.46 billion, chiefly as a result of the additional week in fiscal 2012 and an increase in same store sales, partially offset by store closings. Fourth-quarter same store sales went up 3.0 percent over the prior-year period, consisting of a 1.6 percent growth in the front end and a 3.8 percent rise in the pharmacy.

On average, 6 analysts polled by Thomson Reuters expected loss per share of $0.14 on $6.98 billion revenue for the quarter. Analysts' estimates typically exclude one-time items.

For fiscal 2013, the company sees net loss between $103 million and $267 million or a loss per share of $0.13 - $0.31, while 7 analysts anticipate loss of $0.25 per share for the full year.

In addition, Rite Aid estimates fiscal 2013 sales to be between $25.4 billion and $25.8 billion with same-stores sales expected to range from flat to an increase of 1.5 percent over fiscal 2012, whereas 8 analysts project sales of 25.74 billion for the year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
German business software maker SAP AG on Tuesday raised its forecast for fiscal 2017 and 2020, after reporting higher profit and revenues in its fourth quarter. For fiscal 2017, SAP now expects non-IFRS operating profit in a range of 6.8 billion euros to 7.0 billion euros at constant currencies, compared to 6.63 billion euros in 2016. Dutch consumer electronics giant Philips Electronics NV reported Tuesday a profit in its fourth quarter, compared to last year's loss, mainly reflecting higher sales in its HealthTech portfolio. The company also revealed that it is currently in discussions with the US Department of Justice regarding its external defibrillator business in the U.S. TerraForm Global, Inc., an operator of clean energy power plants, said Monday that it has signed an exclusivity agreement with Brookfield Asset Management Inc. to negotiate a potential business combination between them. Shares of TerraForm Global are gaining more than 6 percent in pre-market activity following the announcement.
comments powered by Disqus
Follow RTT